Purpose: To evaluate the feasibility and safety of stent implantation to treat ostial vertebral artery stenosis.
Method: Fifty-eight symptomatic patients (44 men; mean age 72 years, range 54 to 88) with 67 ostial vertebral artery lesions received 67 balloon-expandable coronary stents. Follow-up angiography was performed if restenosis was suspected or during later catheterization for other indications. Restenosis was defined as >50% diameter narrowing.
Result: Technical success was 100%. Periprocedural neurological complications included 2 (3.4%) posterior and 1 (1.7%) anterior strokes. Other complications included 1 (1.7%) massive gastrointestinal hemorrhage requiring blood transfusion and endoscopic therapy, 1 (1.7%) femoral pseudoaneurysm requiring surgical repair, and 1 (1.7%) large shoulder hematoma secondary to a ruptured small branch of the thoracoacromial artery. Antiplatelet medication was discontinued in the ulcer patient, and the vertebral stent occluded at 8 months. At a mean follow-up of 31.3+/-17.1 months, 1 (1.7%) patient died after coronary bypass 2 months after stenting. One (1.7%) patient reported recurrent dizziness at 14 months and had angiographic evidence of in-stent restenosis. Angiographic evaluation of 32 (48%) lesions at a mean 11.0+/-9.6 months uncovered restenosis in 8 (25%) vessels, including the 2 cases noted above. Aside from these 2 patients, none of the other patients with restenosis were symptomatic. Multivariant Cox regression analysis showed reference vessel diameter as the only independent predictor of restenosis.
Conclusion: Symptomatic ostial vertebral artery stenosis can be treated with relative safety using coronary techniques and equipment. Reference vessel diameter was the only predictor of restenosis in vertebral artery ostial stents.